Support Health Rising’s quickie Summer Donation Drive



Click here for more


No one suspected a 50 year old kidney drug called spironolactone might hold the key to a new generation of herpesvirus drugs.

University of Utah researchers hoped their new assay might uncover a new way to treat EBV infections – but they were shocked at what it turned up. How could a 50 year old kidney drug called Spironolactone have anything to do with EBV?

Four years later they knew how – and the possibility for a more effective drug to treat herpesvirus infections was borne.
The moral to this story – you never know where an answer may come from. It could even be sitting on an aisle in your pharmacy.
Find out more in a Simmaron Research Foundation sponsored blog:
Help keep Health Rising on the Web! Support us during our quickie Summer Fundraising Drive. Click here for more.

Health Rising's Quickie Summer Donation Drive is On!

Community support allows Health Rising to keep the ME/CFS, Long COVID and fibromyalgia communities up to date with the latest research and treatment news. If you find that helpful please support us.

Thanks for your support :)

Pin It on Pinterest

Share This